Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05056688
Recruitment Status : Active, not recruiting
First Posted : September 24, 2021
Last Update Posted : October 1, 2021
Sponsor:
Information provided by (Responsible Party):
Mehmet Salih YILDIRIM, Agri Ibrahim Cecen University

Brief Summary:

Aim: One of the cheapest, easiest and most effective ways to detect testicular cancer early is to resort to early detection screening methods associated with health beliefs about testicular cancer, and the second is to self-examine the testicles. In the country, there are a limited number of studies on the health beliefs and early diagnosis behaviors of young adult men for testicular cancer. For this reason, the study was conducted to determine the effect of online education given to young adults on testicular cancer health beliefs and behavior.

Material and method: The research was conducted as a randomized controlled experimental study. The study population consisted of 768 individuals who applied to Family Health Centers affiliated to Agri Provincial Health Directorate between April 2021 and June 2022, and the sample of the research consisted of 90 individuals selected from the population using the improbable random sampling method. "Descriptive Feature Form", "Champion's Health Belief Model Scale in Testicular Cancer Screenings" were used to collect data. In the analysis of data; percentile distribution, chi-square, Fisher-Freeman-Halton Exact test, t-test in independent groups, Repeated Measures ANOVA Test, Friedman Test, One Way ANOVA test, Kruskall Wallis test, and post hoc analyzes (Bonferroni, Games Howell, Dunn) were used.


Condition or disease Intervention/treatment Phase
Testicular Neoplasms Diagnostic Test: Testicular Model BSE/TSE Training Set Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: In the study, 90 individuals, including 1 experimental and 1 control group, were included in the study.
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors
Actual Study Start Date : April 30, 2021
Actual Primary Completion Date : June 30, 2021
Estimated Study Completion Date : March 30, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Application of training set to experimental group
Testicular Model BSE/TSE Training Set
Diagnostic Test: Testicular Model BSE/TSE Training Set
The investigators will use the Testicular Model BSE/TSE Trainer to transform individuals' routine testicular self-examination into behavior.

No Intervention: Control Group



Primary Outcome Measures :
  1. Giving training to the experimental group for 6 weeks with an interval of 2 weeks. [ Time Frame: Four monts ]
    Individuals in the experimental and control group were evaluated with "Champion's Health Belief Model Scale in Testicular Cancer Screening". The effect of the training given to people in the online training group, which cannot be given to the control group, was changed at the end of 16 weeks with the mid-test "Champion's Health Belief Model Scale in Testicular Cancer Screening". A minimum of 26 points and a maximum of 130 points are obtained from Champion's Health Belief Model Scale in Testicular Cancer Screenings. The sub-dimensions of the scale are evaluated separately and there is no total score.

  2. Collection of the final test [ Time Frame: Three monts ]
    The mid-test for individuals in the experimental and control group was evaluated by the "Champion's Health Belief Model Scale in Testicular Cancer Screening". The effect of training given to those who could not be given to the control group in the online training group was replaced by the "Champion's Health Belief Model Scale in Testicular Cancer Screening" final test 3 months after training. A minimum of 26 points and a maximum of 130 points are obtained from Champion's Health Belief Model Scale in Testicular Cancer Screenings. The sub-dimensions of the scale are evaluated separately and there is no total score.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Being 18-35 years old,
  • Being literate,
  • Computer can be used,
  • Being able to access the Internet,
  • Not having a testicular diagnosis before,
  • Deciding to participate in the research.

Exclusion Criteria:

  • Being outside the age range of 18-35,
  • To be diagnosed with testicular cancer before

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05056688


Locations
Layout table for location information
Turkey
Agri Ibrahim Cecen University
Agri, Turkey, 04100
Sponsors and Collaborators
Agri Ibrahim Cecen University
Investigators
Layout table for investigator information
Principal Investigator: Mehmet Salih YILDIRIM, Ph. D Agri Ibrahim Cecen University
Layout table for additonal information
Responsible Party: Mehmet Salih YILDIRIM, LECTURER, Agri Ibrahim Cecen University
ClinicalTrials.gov Identifier: NCT05056688    
Other Study ID Numbers: AICUNI-YILDIRIM-001
First Posted: September 24, 2021    Key Record Dates
Last Update Posted: October 1, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mehmet Salih YILDIRIM, Agri Ibrahim Cecen University:
Health Belief Model
Health Behavior
Education, Distance
Testicular Neoplasms
Additional relevant MeSH terms:
Layout table for MeSH terms
Testicular Neoplasms
Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Genital Neoplasms, Male
Urogenital Neoplasms
Endocrine System Diseases
Testicular Diseases
Gonadal Disorders